source
- STAT+: Popular insulin product enters shortage as other pens leave marketThe Lantus Solostar insulin pen isn't in official FDA shortage, but patients are having a tough time finding it.STAT · 6d ago↗ source
- Senate health panel delays vote on CDC nomineeToo few senators were in attendance to proceed with a vote on the CDC director nominee.STAT · 6d ago↗ source
- Lilly, with new data, to seek FDA approval of obesity drug retatrutideThe new findings position Lilly to file an application for the highly anticipated medicine, but also leave some questions about the additive benefits a “triple-G” drug has on heart health.BioPharma Dive · 6d ago↗ source